Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects
NCT02634437
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Function
Interventions
DRUG:
Ulipristal acetate
Sponsor
Allergan